In last trading session, Generation Bio Co (NASDAQ:GBIO) saw 0.35 million shares changing hands with its beta currently measuring 2.66. Company’s recent per share price level of $0.38 trading at $0.0 or 1.52% at ring of the bell on the day assigns it a market valuation of $25.56M. That closing price of GBIO’s stock is at a discount of -947.37% from its 52-week high price of $3.98 and is indicating a premium of 15.79% from its 52-week low price of $0.32. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.62 million shares which gives us an average trading volume of 500.98K if we extend that period to 3-months.
For Generation Bio Co (GBIO), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.67. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Generation Bio Co (NASDAQ:GBIO) trade information
Upright in the green during last session for gaining 1.52%, in the last five days GBIO remained trading in the green while hitting it’s week-highest on Monday, 05/12/25 when the stock touched $0.38 price level, adding 9.18% to its value on the day. Generation Bio Co’s shares saw a change of -64.03% in year-to-date performance and have moved 5.92% in past 5-day. Generation Bio Co (NASDAQ:GBIO) showed a performance of 9.92% in past 30-days. Number of shares sold short was 1.13 million shares which calculate 2.09 days to cover the short interests.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -8.30% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 45.62% while estimates for its earnings growth in next 5 years are of 24.37%.
Generation Bio Co (NASDAQ:GBIO)’s Major holders
Insiders are in possession of 14.37% of company’s total shares while institution are holding 71.72 percent of that, with stock having share float percentage of 83.75%. Investors also watch the number of corporate investors in a company very closely, which is 71.72% institutions for Generation Bio Co that are currently holding shares of the company. PRICE T ROWE ASSOCIATES INC /MD/ is the top institutional holder at GBIO for having 9.51 million shares of worth $26.83 million. And as of 2024-06-30, it was holding 14.3205 of the company’s outstanding shares.
The second largest institutional holder is ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC, which was holding about 8.28 million shares on 2024-06-30. The number of shares represents firm’s hold over 12.4628 of outstanding shares, having a total worth of $23.35 million.
On the other hand, T. Rowe Price New Horizons Fund, Inc. and Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 5.34 shares of worth $2.04 million or 7.96% of the total outstanding shares. The later fund manager was in possession of 1.77 shares on Mar 31, 2025 , making its stake of worth around $0.68 million in the company or a holder of 2.65% of company’s stock.
